LPH-48
≈ 3 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
LPH-48 is a selective serotonin 5-HT 2A receptor agonist and psychedelic hallucinogen which is under development for the treatment of alcoholism. Its route of administration has not been specified. The drug acts as a selective agonist of the serotonin 5-HT 2A receptor. It is said to be an analogue of LPH-5 with similar characteristics but with faster metabolism and a shorter duration of action. LPH-5 is a highly selective serotonin 5-HT 2A receptor agonist that is under development for major depressive disorder and has shown antidepressant-like effects in animals. LPH-48 is under development by Lophora. As of May 2024, it is in preclinical research for alcoholism. The chemical structure of LPH-48 does not yet seem to have been disclosed. However, Lophora has patented selective serotonin 5-HT 2A receptor agonists for treatment of depression and the company is said to have patent protection for LPH-48. Additionally, the structure of its close analogue LPH-5 is known and this compound is a phenylpiperidine derivative.
LPH-48 is a selective serotonin 5-HT 2A receptor agonist and psychedelic hallucinogen which is under development for the treatment of alcoholism. Its route of administration has not been specified. The drug acts as a selective agonist of the serotonin 5-HT 2A receptor. It is said to be an analogue of LPH-5 with similar characteristics but with faster metabolism and a shorter duration of action. LPH-5 is a highly selective serotonin 5-HT 2A receptor agonist that is under development for major depressive disorder and has shown antidepressant-like effects in animals. LPH-48 is under development by Lophora. As of May 2024, it is in preclinical research for alcoholism. The chemical structure of LPH-48 does not yet seem to have been disclosed. However, Lophora has patented selective serotonin 5-HT 2A receptor agonists for treatment of depression and the company is said to have patent protection for LPH-48. Additionally, the structure of its close analogue LPH-5 is known and this compound is a phenylpiperidine derivative.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1334893831 under CC BY-SA 4.0; modifications have been made.